# A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

> **NCT07340320** · PHASE2 · RECRUITING · sponsor: **Corxel Pharmaceuticals** · enrollment: 240 (estimated)

## Conditions studied

- Type II Diabetes Mellitus

## Interventions

- **DRUG:** CX11
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07340320
- **Lead sponsor:** Corxel Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-06
- **Primary completion:** 2026-12-23
- **Final completion:** 2027-01-07
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07340320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07340320, "A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07340320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*